CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Insulin detemir

Last Updated: March 10, 2009
Result type: Reports
Project Number: S0172
Product Line: Reimbursement Review

Generic Name: Insulin detemir

Brand Name: Levemir

Manufacturer: Novo Nordisk Canada Inc.

Indications: Diabetes mellitus Type1, Pediatrics

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: August 20, 2009

Recommendation Type: Do not list